Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide.
D015062:11-Hydroxycorticosteroids / Q000097:blood; D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy*; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000315:Adrenalectomy; D000328:Adult; D000616:Aminoglutethimide / Q000627:therapeutic use*; D003480:Cushing Syndrome / Q000150:complications; D003907:Dexamethasone / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008207:Lymphatic Metastasis; D008297:Male; D008939:Mitotane / Q000627:therapeutic use*; D009392:Nephrectomy; D013256:Steroids / Q000652:urine
D015062:11-Hydroxycorticosteroids; D004338:Drug Combinations; D013256:Steroids; D000616:Aminoglutethimide; D008939:Mitotane; D003907:Dexamethasone; D006854:Hydrocortisone